Minireview
British Journal of Cancer (2004) 90, 294–298. doi:10.1038/sj.bjc.6601499 www.bjcancer.com
Published online 20 January 2004
Second primary breast cancer after Hodgkin's disease
- 1Academic Unit of Radiotherapy and Oncology, The Royal Marsden NHS Trust and the Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5NG, UK
- 2Aetiological Epidemiology, The Royal Marsden NHS Trust and the Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5NG, UK
Correspondence: Professor A Horwich, E-mail: alan.horwich@icr.ac.uk
Received 17 July 2003; Revised 15 October 2003; Accepted 27 October 2003.
Abstract
Although the potential carcinogenic risk of radiotherapy is well known, it has become clear that there is a particularly high risk of radiation-induced breast cancer in women treated for Hodgkin's disease at young ages. Thankfully, death from breast cancer in this population is uncommon, but it is important to understand factors contributing to the risk, including treatment parameters, and to develop a logical and efficient method for medical management of those at risk. In this minireview, we examine the evidence which should inform such a management policy.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
